Sign Up to like & get
recommendations!
0
Published in 2017 at "Chemico-biological interactions"
DOI: 10.1016/j.cbi.2017.09.008
Abstract: During preclinical development of canagliflozin, an SGLT2 inhibitor, treatment-related pheochromocytomas, renal tubular tumors (RTT), and testicular Leydig cell tumors were reported in the 2-year rat toxicology study. In a previous 6-month rat mechanistic study, feeding…
read more here.
Keywords:
rat study;
malabsorption;
adrenal medullary;
canagliflozin ... See more keywords